日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CETSA-MS unveils novel targets engaged by rigosertib to promote anti-tumor activity and inflammatory responses.

CETSA-MS 揭示了 rigosertib 促进抗肿瘤活性和炎症反应的新靶点

Kechagioglou Petros, Yurugi Hajime, Dupont Camille, Chernobrovkin Alexey, Romero Rossana, Harms Gregory, Oster Marie, Ciesek Sandra, Tweedell Rebecca, Kanneganti Thirumala-Devi, Zimmer Stefanie, Cosenza Stephen, Fruchtman Steven M, Rajalingam Krishnaraj

MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response

经 GalNAc 糖簇修饰的 MUC1 糖肽疫苗靶向树突状细胞上的巨噬细胞半乳糖 C 型凝集素,从而诱导更强的体液免疫应答。

Gabba, Adele; Attariya, Riem; Behren, Sandra; Pett, Christian; van der Horst, Joost C; Yurugi, Hajime; Yu, Jin; Urschbach, Moritz; Sabin, Juan; Birrane, Gabriel; Schmitt, Edgar; van Vliet, Sandra J; Besenius, Pol; Westerlind, Ulrika; Murphy, Paul V

Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors

全身给药的TLR7/8激动剂和抗原偶联纳米凝胶调控抗肿瘤免疫反应

Stickdorn, Judith; Stein, Lara; Arnold-Schild, Danielle; Hahlbrock, Jennifer; Medina-Montano, Carolina; Bartneck, Joschka; Ziß, Tanja; Montermann, Evelyn; Kappel, Cinja; Hobernik, Dominika; Haist, Maximilian; Yurugi, Hajime; Raabe, Marco; Best, Andreas; Rajalingam, Krishnaraj; Radsak, Markus P; David, Sunil A; Koynov, Kaloian; Bros, Matthias; Grabbe, Stephan; Schild, Hansjörg; Nuhn, Lutz

Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases

抑制性配体:对抗癌症、骨质疏松症、炎症、心脏病和神经系统疾病的日益强大的武器库

Wang, Dong; Tabti, Redouane; Elderwish, Sabria; Abou-Hamdan, Hussein; Djehal, Amel; Yu, Peng; Yurugi, Hajime; Rajalingam, Krishnaraj; Nebigil, Canan G; Désaubry, Laurent